Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication
- PMID: 15627030
- DOI: 10.1097/00002030-200501030-00003
Persistent low viral load on antiretroviral therapy is associated with T cell-mediated control of HIV replication
Abstract
Background: It is unclear how stable low-level viral replication and CD4 cell numbers can be maintained under highly active antiretroviral therapy (HAART). This study was designed to analyse whether HIV-specific responses in stable partially controlled patients during antiretroviral therapy (ART) differ from those observed in complete HAART failure and whether they contribute to the control of viral load (VL).
Methods: Three groups of patients were selected according to plasma HIV RNA levels during 18 months of ART: persistently low VL (LoVL; HIV RNA <10,000 copies/ml; n = 28), undetectable VL (UnVL; HIV RNA <200 copies/ml; n = 29) and high VL (HiVL; HIV RNA >10,000 copies/ml; n = 14). T-cell responses were studied using lymphoproliferative and interferon (IFN)-gamma-ELISpot assays against HIV-p24, -gp160, recall antigens, and 15 pools of HIV-(Gag + RT) peptides.
Results: Frequencies of IFN-gamma-producing CD4 T cells against HIV-p24 were higher in LoVL than in UnVL or HiVL groups [median, 131, 47 and 23 spot-forming cells (SFC)/1 x 10 peripheral blood mononuclear cells (PBMC), respectively; P = 0.012 and P = 0.047]. Lymphoproliferative responses to HIV-p24 and recall antigens were similar in LoVL and UnVL groups but lower in HiVL (P = 0.004). Frequencies of HIV-specific CD8 T cells were higher in LoVL than in UnVL (1340 versus 410 SFC/1 x 10 PBMC; P = 0.001). They correlated negatively with VL in the LoVL and HiVL (r, -0.393, P = 0.039 and r, -0.643, P = 0.024, respectively) and positively correlated with anti-HIV CD4 cell frequencies in the LoVL group only (r, 0.420; P = 0.026).
Conclusion: Persistently low viral replication (<10,000 copies/ml) during ART stimulates high frequencies of HIV-specific CD4 and CD8 T cells compared to full virus suppression or complete ART failure. The association of high anti-HIV activity with large numbers of HIV-specific CD8 T cells contribute to the control of viral replication.
Similar articles
-
Persistent HIV-1 replication does not explain low levels of T-cell interferon-gamma mRNA and elevated serum NO(2) (-)/NO(3) (-) in patients with stable CD4 T-cell responses to HAART.Clin Exp Immunol. 2004 Oct;138(1):110-5. doi: 10.1111/j.1365-2249.2004.02589.x. Clin Exp Immunol. 2004. PMID: 15373912 Free PMC article.
-
Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.AIDS. 2000 Sep 8;14(13):1921-33. doi: 10.1097/00002030-200009080-00007. AIDS. 2000. PMID: 10997396 Clinical Trial.
-
Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.AIDS Res Hum Retroviruses. 2006 Mar;22(3):272-82. doi: 10.1089/aid.2006.22.272. AIDS Res Hum Retroviruses. 2006. PMID: 16545014
-
Harnessing CD8+ T Cells Under HIV Antiretroviral Therapy.Front Immunol. 2019 Feb 26;10:291. doi: 10.3389/fimmu.2019.00291. eCollection 2019. Front Immunol. 2019. PMID: 30863403 Free PMC article. Review.
-
New antiretroviral drugs and approaches to HIV treatment.AIDS. 2003;17 Suppl 4:S85-96. doi: 10.1097/00002030-200317004-00010. AIDS. 2003. PMID: 15080184 Review. No abstract available.
Cited by
-
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.Retrovirology. 2007 Apr 6;4:25. doi: 10.1186/1742-4690-4-25. Retrovirology. 2007. PMID: 17417971 Free PMC article.
-
Evaluation of the interlaboratory concordance in quantification of human immunodeficiency virus-specific T cells with a gamma interferon enzyme-linked immunospot assay.Clin Vaccine Immunol. 2006 Jun;13(6):684-97. doi: 10.1128/CVI.00387-05. Clin Vaccine Immunol. 2006. PMID: 16760328 Free PMC article.
-
Influence of episodes of intermittent viremia ("blips") on immune responses and viral load rebound in successfully treated HIV-infected patients.AIDS Res Hum Retroviruses. 2013 Jan;29(1):68-76. doi: 10.1089/AID.2012.0145. Epub 2012 Dec 16. AIDS Res Hum Retroviruses. 2013. PMID: 23121249 Free PMC article. Clinical Trial.
-
Neutralizing antibody responses against autologous and heterologous viruses in acute versus chronic human immunodeficiency virus (HIV) infection: evidence for a constraint on the ability of HIV to completely evade neutralizing antibody responses.J Virol. 2006 Jun;80(12):6155-64. doi: 10.1128/JVI.00093-06. J Virol. 2006. PMID: 16731954 Free PMC article.
-
No increase in hepatitis B virus (HBV)-specific CD8+ T cells in patients with HIV-1-HBV coinfections following HBV-active highly active antiretroviral therapy.J Virol. 2010 Mar;84(6):2657-65. doi: 10.1128/JVI.02124-09. Epub 2010 Jan 6. J Virol. 2010. PMID: 20053751 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials